Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of Nasobol®, an Intra-Nasal Testosterone Product, for Testosterone Replacement in Hypogonadal Men

NCT00975650 is registered in ClinicalTrials.gov with Acerus Pharmaceuticals Corporation as lead sponsor.

NCT NCT00975650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00975650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of Nasobol®, an Intra-Nasal Testosterone Product, for Testosterone Replacement in Hypogonadal Men
Lead sponsor
Acerus Pharmaceuticals Corporation
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2009
Completion date
May 31, 2010
Enrollment
57 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism